Founded in February 2001, the company is positioned to capitalize on the enormous opportunity resulting from the genomics revolution by providing pharmaceutically active and selective new drug candidates to a broad, expanded range of well-validated biological targets.

Located in Cambridge, Massachusetts, Infinity has established access to a human capital pool including renowned scientists; prominent entrepreneurs and business executives from the biotechnology, high technology, and consulting sectors; and leading financiers.